Embed Size (px)
Citation preview
Sc
ien
tific
Pro
gra
mOn-line registration
www.paris-nash-symposium.org
June 30, July 1, 2016, Paris
Scientific Program
TRANSLATING DISCOVERY TO HEALTHCARE
Thursday, June 30, 201609:30-09:35 am Welcome Remarks Arun Sanyal (US) & Lawrence Serfaty (F) 09:35-09:45 am Address by Christian Bréchot, Director Institut Pasteur
09:45-11:15 am Session 1: Quantification of burden of disease Chairs: Victor de Ledinghen (F) & Mary Rinella (US) Modeling the epidemic of NAFLD and burden on healthcare system Homi Razawi (US) Variability of disease state transitions based on clinical phenotype and country of origin Lawrence Serfaty (F) NAFLD in pediatric populations: does it affect population health outcomes Jeffrey Schwimmer (US) The burden of NASH in pathology: how to recognize and how to score Pierre Bedossa (F)
11:15-11:40 am Coffee break
11:40-01:30 pm Session 2: NAFLD and non-hepatic outcomes Chairs: Saul Karpen (US) & Stanislas Pol (F) NAFLD and cardiovascular disease: what is the connection? Mary Rinella (US) NAFLD and cancer predeliction: mechanistic and clinical implications Yujin Hoshida (US) Reproductive health in NAFLD Sophie Christin-Maitre (F) Is a bit of alcohol good for the subject with NAFLD? Philippe Mathurin (F) Lifestyle and cancer Jean-François Dufour (SWI)
01:30-02:30 pm Lunch*
02:30-04:00 pm Session 3: Best practices in managing NAFLD outside of hepatologists office Chairs: Hélène Hanaire (F) & Arun Sanyal (US) How diabetologists manage NAFLD in the USA Yehuda Handelsman (US) How diabetologists manage NAFLD in Europe Bertrand Cariou (F) Diabetes and NAFLD- the hepatologists perspective Vlad Ratziu (F) Does diabetes control and the means for achieving control affect various phenotypes of NAFLD Kenneth Cusi (US)
04:00-04:30 pm Coffee break
04:30-06:30 pm Session 4: Emerging toolkit for NAFLD Chairs: Jérôme Boursier (F) & Jeffrey Schwimmer (US) How MR technology may help the clinician Claude Sirlin (US) Transcriptomic classification of NASH and the future of precision medicine Arun Sanyal (US) Ultrasound elastography and its applications for NASH Laurent Castéra (F) In vitro liver models and their applications for NASH Ajit Dash (US) Immune activators of disease progression-diagnostic and therapeutic implications Gyongi Szabo (US)
Fr iday, July 1, 201608:30-10:00 am Session 5: Bile acids and NAFLD Chairs: Phillip Hylemon (US) & Raoul Poupon (F) Bile acids, insulin-signaling and the metabolic syndrome Bart Staels (F) Separating the metabolic benefits from lipoprotein abnormalities associated with FXR agonists-gut vs liver effects Saul Karpen (US) Non-FXR mediated benefits of bile acids on NAFLD Huiping Zhou (US) Antifibrotic mechanisms of FXR David Brenner (US)
10:00-10:20 am Coffee break*
10:20-11:30 am Session 6: The microbiome in metabolic syndrome of NAFLD Chairs: Harry Sokol (F) & Gyongi Szabo (US) The microbiome in liver disease- moving from description to mechanisms Patrick Gillevet (US) The bile acid biome and its relevance for NAFLD and oncogenesis Philip Hylemon (US) Gut dysbiosis and NAFLD Gabriel Perlemuter (F)
11:30-12:00 pm Session 7: Regulatory issues in NAFLD Moderator: Patrick Marcellin (F) Special Lecture: Update from the Liver Forum and the IOM initiative Veronica Miller (US)
12:00-01:00 pm Sponsor Session Chairs: Arun Sanyal (US) & Lawrence Serfaty (F) Challenges and opportunities to harmonize in phase 2B-3 programs in precirrhotic subjects Challenges and opportunities to harmonize in phase 2B-3 programs in cirrhotic subjects
01:00-01:05 pm Closing remarks Arun Sanyal (US) & Lawrence Serfaty (F)
01:05-02:00 pm Lunch
June 30, July 1, 2016, Paris
INSTITUT PASTEUR28 Rue du Docteur Roux75015 PARIS • FRANCE
Congress Secretar iatQuadrature Santé43 rue des Tilleuls • 92100 Boulogne-Billancourt
Contacts:
Claire [email protected]
Lony CASTANS-BOITEAU [email protected]
Noëllie [email protected]
Phone: +33 1 41 10 46 67 +33 1 83 62 81 67
Pract ical InformationNearest public parking:Sogeparc France - 81 rue Falguière - 75015 ParisPhone: +33 1 43 35 27 69
By Metro: Stop at the station Volontaires (Line 12) or Pasteur (Line 6 & 12). 5 minutes walking distance
By Bus:
> Bus #95: stop at the station Institut Pasteur (Nearest stop)
> Buses #39 & #70: stop at the station Volontaires-Vaugirard or Sèvres-Lecourbe. 5 to 10 minutes walking distance
Registrat ion feePr, Dr, MD, Ph.D: 300 € TTCAFEF - SFD member: 150 € TTC Student/Fellow: 75 € TTC
Registration fee includesAccess to all congress sessions and exhibition area, delegate bag, coffee breaks and lunches during the congress
TransportSPECIAL CONGRESS RATES
> Amplitudes Agency Contact : Bernard DEURRIEU Email : [email protected] Phone: +33 1 53 79 77 04
>
Event ID Code to keep for the booking: 2 7 6 5 4 A FMore details here
On-line registrationDeadline: May 20, 2016
The Paris NASH Symposium is supported by
* Thursday lunch is organized with the support of GALMED PHARMACEUTICALS* Friday coffee breaks are organized with the support of TOBIRA THERAPEUTICS
T BIRAT H E R A P E U T I C S
